Category: Public Health

Mister P for surveys in epidemiology — using Stan!

Jon Zelner points us to this new article in the American Journal of Epidemiology, “Multilevel Regression and Poststratification: A Modelling Approach to Estimating Population Quantities From Highly Selected Survey Samples,” by Marnie Downes, Lyle Gurrin, Dallas English, Jane Pirkis, Dianne Currier, Matthew Spittal, and John Carlin, which begins: Large-scale population health studies face increasing difficulties […]

Postdoc in Chicago on statistical methods for evidence-based policy

Beth Tipton writes: The Institute for Policy Research and the Department of Statistics is seeking applicants for a Postdoctoral Fellowship with Dr. Larry Hedges and Dr. Elizabeth Tipton. This fellowship will be a part of a new center which focuses on the development of statistical methods for evidence-based policy. This includes research on methods for […]

Evidence distortion in clinical trials

After seeing our recent post, “Seeding trials”: medical marketing disguised as science, Till Bruckner sent me this message: I’ve been working on clinical trial transparency issues for over two years now, first for AllTrials and now for TranspariMED, and can assure you that this is only the tip of the iceberg. This report by Transparency […]

Don’t worry, the post will be coming . . . eventually

Jordan Anaya sends along a link and writes: Not sure if you’re planning on covering this, but I noticed this today. This could also maybe be another example of the bullshit asymmetry principle since the original paper has an altmetric of 1300 and I’m not sure the rebuttal will get as much attention. I replied […]

Does diet soda stop cancer? Two Yale Cancer Center docs have diametrically opposite views!

Check out these two quotes regarding a recent study, “Associations of artificially sweetened beverage intake with disease recurrence and mortality in stage III colon cancer.” First there’s the claim: Artificially sweetened drinks have a checkered reputation in the public because of the purported health risks that have never really been documented. Our study clearly shows […]

“Objective: Generate evidence for the comparative effectiveness for each pairwise comparison of depression treatments for a set of outcomes of interest.”

Mark Tuttle points us to this project by Martijn Schuemie and Patrick Ryan: Large-Scale Population-Level Evidence Generation Objective: Generate evidence for the comparative effectiveness for each pairwise comparison of depression treatments for a set of outcomes of interest. Rationale: In current practice, most comparative effectiveness questions are answered individually in a study per question. This […]

Did she really live 122 years?

Even more famous than “the Japanese dude who won the hot dog eating contest” is “the French lady who lived to be 122 years old.” But did she really? Paul Campos writes: Here’s a statistical series, laying out various points along the 100 longest known durations of a particular event, of which there are billions […]

The post Did she really live 122 years? appeared first on Statistical Modeling, Causal Inference, and Social Science.

When “nudge” doesn’t work: Medication Reminders to Outcomes After Myocardial Infarction

Gur Huberman points to this news article by Aaron Carroll, “Don’t Nudge Me: The Limits of Behavioral Economics in Medicine,” which reports on a recent study by Kevin Volpp et al. that set out “to determine whether a system of medication reminders using financial incentives and social support delays subsequent vascular events in patients following […]

The post When “nudge” doesn’t work: Medication Reminders to Outcomes After Myocardial Infarction appeared first on Statistical Modeling, Causal Inference, and Social Science.

When “nudge” doesn’t work: Medication Reminders to Outcomes After Myocardial Infarction

Gur Huberman points to this news article by Aaron Carroll, “Don’t Nudge Me: The Limits of Behavioral Economics in Medicine,” which reports on a recent study by Kevin Volpp et al. that set out “to determine whether a system of medication reminders using financial incentives and social support delays subsequent vascular events in patients following […]

The post When “nudge” doesn’t work: Medication Reminders to Outcomes After Myocardial Infarction appeared first on Statistical Modeling, Causal Inference, and Social Science.

Classifying yin and yang using MRI

Zad Chow writes: I wanted to pass along this study I found a while back that aimed to see whether there was any possible signal in an ancient Chinese theory of depression that classifies major depressive disorder into “yin” and “yang” subtypes. The authors write the following, The “Yin and Yang” theory is a fundamental […]

The post Classifying yin and yang using MRI appeared first on Statistical Modeling, Causal Inference, and Social Science.

Classifying yin and yang using MRI

Zad Chow writes: I wanted to pass along this study I found a while back that aimed to see whether there was any possible signal in an ancient Chinese theory of depression that classifies major depressive disorder into “yin” and “yang” subtypes. The authors write the following, The “Yin and Yang” theory is a fundamental […]

The post Classifying yin and yang using MRI appeared first on Statistical Modeling, Causal Inference, and Social Science.

Should we be concerned about MRP estimates being used in later analyses? Maybe. I recommend checking using fake-data simulation.

Someone sent in a question (see below). I asked if I could post the question and my reply on blog, and the person responded: Absolutely, but please withhold my name because this is becoming a touchy issue within my department. The boldface was in the original. I get this a lot. There seems to be […]

The post Should we be concerned about MRP estimates being used in later analyses? Maybe. I recommend checking using fake-data simulation. appeared first on Statistical Modeling, Causal Inference, and Social Science.

Should we be concerned about MRP estimates being used in later analyses? Maybe. I recommend checking using fake-data simulation.

Someone sent in a question (see below). I asked if I could post the question and my reply on blog, and the person responded: Absolutely, but please withhold my name because this is becoming a touchy issue within my department. The boldface was in the original. I get this a lot. There seems to be […]

The post Should we be concerned about MRP estimates being used in later analyses? Maybe. I recommend checking using fake-data simulation. appeared first on Statistical Modeling, Causal Inference, and Social Science.

These 3 problems destroy many clinical trials (in context of some papers on problems with non-inferiority trials, or problems with clinical trials in general)

Paul Alper points to this news article in Health News Review, which says: A news release or story that proclaims a new treatment is “just as effective” or “comparable to” or “as good as” an existing therapy might spring from a non-inferiority trial. Technically speaking, these studies are designed to test whether an intervention is […]

The post These 3 problems destroy many clinical trials (in context of some papers on problems with non-inferiority trials, or problems with clinical trials in general) appeared first on Statistical Modeling, Causal Inference, and Social Science.